Maxar Technologies can’t just ignore short report, Christine Poole says

Christine Poole
A negative report this week by US short seller Spruce Point Capital has caused a steep dropoff in share price for aerospace tech company Maxar Technologies (NYSE, TSX:MAXR).

The best way to avert further damage, says Christine Poole of GlobeInvest Capital Management, is for management to come out and directly respond to the allegations.

Already a poor performer in 2018, MAXR stock dropped a further 13 per cent on Tuesday as investors reacted to the report which claims that Maxar, formerly Macdonald, Dettwiler & Associates, has a 100 per cent downside risk as a result of “financial strains and a brazen accounting scheme to mask failures from its levered acquisitions,” namely, satellite company Space Systems Loral acquired in 2012 and space imagery and remote sensing firm DigitalGlobe acquired in 2017.

Spruce Point charges that Maxar has consistently overstated earnings through “aggressive accounting maneuvers” and that its new CEO, Howard Lance, has been less than forthcoming on his previous leadership roles in two companies that themselves had published misleading financial documents. In effect, the report claims, Maxar has declining organic revenues of negative 12.7 per cent and should be valued at $20 to $25 on an intermediate timeframe, less than half its current value. (All figures in US dollars.)

So far, management has provided a terse response, saying the Spruce Point report is a “direct attempt by a short-seller to profit, at the expense of Maxar shareholders, by manipulating Maxar’s stock price” and that management “continues to be fully committed to transparency in all of its investor presentations and financial reports.”

Probably not good enough, says Poole, CEO and Managing Director at GlobeInvest, who spoke to BNN Bloomberg on Wednesday. “[Ben Axler, Founder of Spruce Point] is saying that there’s a lot of debt and that he doesn’t think the company can pay it back and deliver as quickly as they say. And he had some negative things to say about the new CEO and some accounting issues that he has,” says Poole. “I don’t think the company has come out to address any of this and maybe they should say something,” she argues.

Maxar’s stock had plunged 20 per cent in late February in response to its fiscal fourth quarter and full-year 2017 earnings report, which featured higher revenues related to its DigitalGlobe business but lower revenues from Space Systems to go along with management guidance which estimated a revenue decline of between two and four per cent for the upcoming fiscal year.

“The satellite business for MacDonald-Dettweiler was slowing quite a bit and it looked like it was going to stay soft for a while, so that’s why we got out of the stock [in 2017],” says Poole.

“I can’t comment specifically if there’s any substance behind [the Spruce Point report] but obviously, this hedge fund, I think they’ve done it for a number of years and he’s had some success, so obviously some people are listening,” she said.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: maxr
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

JUSH stock is a buy, Beacon says

With its first quarter results on deck, Beacon Securities analyst Russell Stanley thinks Jushi Holdings (Jushi Holdings Stock Quote, Chart,… [Read More]

17 hours ago

Is Curaleaf stock still a buy?

The stock has been a steady climber since last October, but ahead of earnings is Curaleaf (Curaleaf Stock Quote, Chart,… [Read More]

19 hours ago

OpenText price target cut at National Bank

Following third quarter results he describes as "in-line", National Bank Financial analyst Richard Tse has cut his price target on… [Read More]

20 hours ago

Silicon Motion stock still a buy, Roth says

Following the company's first quarter results, Roth MKM analyst Suji Desilava remains bullish on Silicon Motion Technology (Silicon Motion Technology… [Read More]

21 hours ago

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

4 days ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

4 days ago